Sasan Karimi

Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome

Patrick G. Morris, Denise D. Correa, Joachim Yahalom et al. · Journal of Clinical Oncology · 2013 · 491 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Safety and Efficacy of Bevacizumab With Hypofractionated Stereotactic Irradiation for Recurrent Malignant Gliomas

Philip H. Gutin, Fábio M. Iwamoto, Kathryn Beal et al. · International Journal of Radiation Oncology*Biology*Physics · 2009 · 373 citations

Medicine, Oncology, Radiation Oncology +13

Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma

Thomas Kaley, Patrick Y. Wen, David Schiff et al. · Neuro-Oncology · 2014 · 289 citations · Full text

Medicine, Oncology, Pharmacology +16

YKL-40 and Matrix Metalloproteinase-9 as Potential Serum Biomarkers for Patients with High-Grade Gliomas

Adı́lia Hormigo, Bin Gu, Sasan Karimi et al. · Clinical Cancer Research · 2006 · 181 citations

Medicine, Neurology, Oncology +13

Randomized Phase II Trial of Chemoradiotherapy Followed by Either Dose-Dense or Metronomic Temozolomide for Newly Diagnosed Glioblastoma

Jennifer Clarke, Fábio M. Iwamoto, Joohee Sul et al. · Journal of Clinical Oncology · 2009 · 177 citations · Full text

Medicine, Oncology, Pharmacology +17